دوره 24، شماره 1 - ( 1400 )                   جلد 24 شماره 1 صفحات 45-54 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

alizadeh R, Azadmanesh K, Arashkia A, Ghanei M. Protocol for Recovery of Measles Virus from Intact/Recombinant Antigenomic DNA. mjms. 2021; 24 (1) :45-54
URL: http://mjms.modares.ac.ir/article-30-52359-fa.html
پروتوکل ساخت ویروس سرخک از توالی آنتی ژنومیک نوترکیب و غیر نو ترکیب. Pathobiology Research. 1400; 24 (1) :45-54

URL: http://mjms.modares.ac.ir/article-30-52359-fa.html


چکیده:   (240 مشاهده)


 
Measles virus, negative-strand RNA viruses, has been known as an ideal candidate in oncolytic virotherapy.  Recombinant measles virus can encode genes of interests for reaching several aims. Replication efficiency of oncolytic virus in tumoral cells is a key parameter in efficient tumor eradication. Products of P gene (P/V/C) support measle virus to circumvent IFN 1 as the main response of innate immune system against viruses. But vaccine strains used in oncolytic therapy studies comprise several mutations in their P gene sequences. These mutations affect replication efficacy which cause attenuation of measles strains applicable in vaccination. So, arming vaccine strains with the wild type P gene is helpful to reach high virus titer. Here at this study, we have expanded a protocol with details for engineering and efficient recovery of measles virus for different aims.   
متن کامل [PDF 959 kb]   (53 دریافت)    
نوع مقاله: پژوهشي اصيل | موضوع مقاله: فرآورده های بیولوژیک
دریافت: 1400/2/18 | پذیرش: 1400/4/21

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA